Literature DB >> 10190540

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy.

G W Pogson1, L H Kindred, B G Carper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190540     DOI: 10.1016/s0002-9149(99)00034-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  12 in total

Review 1.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Clinical pharmacokinetics of cerivastatin.

Authors:  W Mück
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

Review 4.  Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.

Authors:  T K Lau; D R Leachman; R Lufschanowski
Journal:  Tex Heart Inst J       Date:  2001

Review 5.  Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century.

Authors:  T A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 6.  Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.

Authors:  G L Plosker; C I Dunn; D P Figgitt
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 7.  Does differing metabolism by cytochrome p450 have clinical importance?

Authors:  M H Davidson
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.113

8.  Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate.

Authors:  Manyun Dai; Julin Yang; Minzhu Xie; Jiao Lin; Min Luo; Huiying Hua; Gangming Xu; Hante Lin; Danjun Song; Yuqing Cheng; Bin Guo; Jinshun Zhao; Frank J Gonzalez; Aiming Liu
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

Review 9.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 10.  Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.

Authors:  Jianyong Wu; Yan Song; Heng Li; Jianghua Chen
Journal:  Eur J Clin Pharmacol       Date:  2009-09-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.